HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical evaluation of rosoxacin for the treatment of chancroid.

Abstract
One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. Ulcers and buboes were followed clinically and bacteriologically for 1 month. Of 40 evaluable males on the 3-day regimen, 38 (95%) were cured, while only 14 of 23 (61%) males on the single-dose regimen were cured; this regimen was discontinued. There was one ulcer relapse at day 21 in both groups; the one relapse in the single-dose group had a persistent culture-positive bubo. Eight of nine (89%) buboes followed to the endpoint on the 3-day rosoxacin regimen were cured, versus three of six (50%) on the single-dose regimen. Adverse effects were mainly related to the central nervous system but were minor and did not require intervention. None of the treatment failures was due to organisms resistant to rosoxacin, and failure of the single-dose regimen presumably was related to duration of tissue levels rather than to drug resistance. Administration of 150 mg of rosoxacin twice daily for 3 days is an effective regimen for the therapy of chancroid and is a reasonable alternative to other short-course regimens.
AuthorsD A Haase, J O Ndinya-Achola, R A Nash, L J D'Costa, D Hazlett, S Lubwama, H Nsanze, A R Ronald
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 30 Issue 1 Pg. 39-41 (Jul 1986) ISSN: 0066-4804 [Print] United States
PMID3489439 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 4-Quinolones
  • Anti-Infective Agents
  • Anti-Infective Agents, Urinary
  • Quinolines
  • Quinolones
  • rosoxacin
Topics
  • 4-Quinolones
  • Adult
  • Anti-Infective Agents
  • Anti-Infective Agents, Urinary (adverse effects, therapeutic use)
  • Chancroid (drug therapy, microbiology)
  • Haemophilus ducreyi (drug effects)
  • Humans
  • Male
  • Quinolines (adverse effects, therapeutic use)
  • Quinolones

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: